Infertility Therapeutics Market: By Drug Class, Biguanides, Others), By Route of Administration , By Gender, By Distribution Channels, and Region Forecast 2020-2031  

download arrow download arrow Download Sample
settings arrow settings arrow email us

Infertility Therapeutics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Class (Gonadotropin, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Biguanides, Others), By Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular), By Gender (Men, Women), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region Forecast 2020-2031  

Report ID:62124

Published Date:Apr 2023

No of Pages:

Format:

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

1. Executive Summary
2. Global Infertility Therapeutics Market Introduction
2.1. Global Infertility Therapeutics Market – Taxonomy
2.2. Global Infertility Therapeutics Market –Definitions
2.2.1. By Drug Class
2.2.2. By Route of Administration
2.2.3. By Gender
2.2.4. By Distribution Channels
2.2.5. By Region
3. Global Infertility Therapeutics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Infertility Therapeutics Market Dynamic Factors - Impact Analysis
3.6. Global Infertility Therapeutics Market – Competition Landscape
4. Global Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Infertility Therapeutics Market, By Drug Class, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.1. Gonadotropin
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Aromatase Inhibitors
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Selective Estrogen Receptor Modulators (SERMs)
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Biguanides
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Infertility Therapeutics Market, By Route of Administration, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.1. Oral
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Intravenous
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Subcutaneous
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Intramuscular
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Infertility Therapeutics Market, By Gender, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
7.1. Men
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Women
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Infertility Therapeutics Market, By Distribution Channels, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online Pharmacies
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Infertility Therapeutics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Region, 2022-2028
10. North America Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
10.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Gonadotropin
10.1.2. Aromatase Inhibitors
10.1.3. Selective Estrogen Receptor Modulators (SERMs)
10.1.4. Biguanides
10.1.5. Others
10.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Oral
10.2.2. Intravenous
10.2.3. Subcutaneous
10.2.4. Intramuscular
10.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Men
10.3.2. Women
10.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Country, 2022-2028
10.7. North America Infertility Therapeutics Market Dynamics – Trends
11. Europe Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
11.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Gonadotropin
11.1.2. Aromatase Inhibitors
11.1.3. Selective Estrogen Receptor Modulators (SERMs)
11.1.4. Biguanides
11.1.5. Others
11.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Oral
11.2.2. Intravenous
11.2.3. Subcutaneous
11.2.4. Intramuscular
11.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Men
11.3.2. Women
11.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Country, 2022-2028
11.7. Europe Infertility Therapeutics Market Dynamics – Trends
12. Asia-Pacific Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
12.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Gonadotropin
12.1.2. Aromatase Inhibitors
12.1.3. Selective Estrogen Receptor Modulators (SERMs)
12.1.4. Biguanides
12.1.5. Others
12.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Oral
12.2.2. Intravenous
12.2.3. Subcutaneous
12.2.4. Intramuscular
12.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Men
12.3.2. Women
12.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, by Drug Class, By Distribution Channels, and Country, 2022-2028
12.7. Asia-Pacific Infertility Therapeutics Market Dynamics – Trends
13. Latin America Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
13.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Gonadotropin
13.1.2. Aromatase Inhibitors
13.1.3. Selective Estrogen Receptor Modulators (SERMs)
13.1.4. Biguanides
13.1.5. Others
13.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Oral
13.2.2. Intravenous
13.2.3. Subcutaneous
13.2.4. Intramuscular
13.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Men
13.3.2. Women
13.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Country, 2022-2028
13.7. Latin America Infertility Therapeutics Market Dynamics – Trends
14. Middle East and Africa Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
14.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Gonadotropin
14.1.2. Aromatase Inhibitors
14.1.3. Selective Estrogen Receptor Modulators (SERMs)
14.1.4. Biguanides
14.1.5. Others
14.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Oral
14.2.2. Intravenous
14.2.3. Subcutaneous
14.2.4. Intramuscular
14.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Men
14.3.2. Women
14.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf CoDistribution Channels Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Country, 2022-2028
14.7. MEA Infertility Therapeutics Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key products, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Abbott Laboratories
15.2.2. Takeda Pharmaceutical Company Limited
15.2.3. Ferring Pharmaceuticals Inc.
15.2.4. Pfizer Inc.
15.2.5. Novartis International AG
15.2.6. Bayer AG
15.2.7. Teva Pharmaceticals Industries
15.2.8. Merck & Co., Inc.
15.2.9. Vitrolife AB
15.2.10. MedGyn Products, Inc.
16. Research Methodology
17. Key Assumptions and Acronyms

 

Key Features of the Report

  • The market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Content Updated Date: Jan 2025

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

Key Market Players

 

  • Abbott Laboratories
  • Takeda Pharmaceutical Company Limited
  • Ferring Pharmaceuticals Inc.
  • Pfizer Inc.
  • Novartis International AG
  • Bayer AG
  • Teva Pharmaceticals Industries
  • Merck & Co., Inc.
  • Vitrolife AB
  • MedGyn Products, Inc.

Related Industry Reports

Bio adhesive Ophthalmic Treatments Market

Medicinal Chemistry Market

Medical Oxygen Market

Paediatric Healthcare Market